Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Terminated 2Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 17Gastrointestinal 8Thoracic 5Head & Neck 5Tumor-Agnostic 2Other hematologic neoplasm 2Lymphoid 2Gynecologic 2Genitourinary 2Other 1CNS 1

Conditions

Uterine Cervical Dysplasia 1Pain, Postoperative 1Endometrial Neoplasms 1Endometrial Hyperplasia 1

Interventions

Paclitaxel 264Carboplatin 246Cisplatin 153Bevacizumab 104Gemcitabine 78Topotecan 77liposomal doxorubicin 67pembrolizumab 60Docetaxel 56Cyclophosphamide 50Taxes 48Radiotherapy 44olaparib 43Surveys and Questionnaires 43Doxorubicin 43Filgrastim 42Brachytherapy 37Drug Therapy 31niraparib 28Blood Specimen Collection 28Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 26human papillomavirus vaccine, L1 type 16, 18 24Peripheral Blood Stem Cell Transplantation 23atezolizumab 22Oxaliplatin 22Pemetrexed 21Nivolumab 21Hyperthermic Intraperitoneal Chemotherapy 21Etoposide 21Immunoglobulin G 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Bupivacaine × Gynecologic × Clear all
NCT05763667 2025-04-24

Pilot: Intraoperative TAP Block and Post-operative Pain Control for Minimally Invasive Hysterectomy for Endometrial Cancer

Tufts Medical Center

Phase 3 Completed
15 enrolled
Gynecologic

Endometrial Hyperplasia, Pain, Postoperative, Endometrial Neoplasms

NCT02368054 2016-08-19

HSBAPCB

Helse Fonna

Phase 4 Completed
34 enrolled
Gynecologic

Uterine Cervical Dysplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡